The evaluation of cardiac functions according to chronic obstructive pulmonary disease groups

References

• Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2017. Available from: http://goldcopd.org.
   Google Scholar
• Canguven O, El Ansari W, Yassin A. Vitamin D supplementation as a potential therapeutic mediator in asthma: does dose really matter? A critical review of the literature. Aging Male. 2018;1:1–8.
   Google Scholar
• Friedlander AL, Lynch D, Dyar LA, et al. Phenotypes of chronic obstructive pulmonary disease. COPD. 2007;4:355–384.
   PubMedGoogle Scholar
• Metin Ökmen B, Şengören Dikiş Ö, Ökmen K, et al. Investigation of the effect of kinesiotaping on the respiratory function and depression in male patients with chronic obstructive pulmonary disease: a prospective, randomized, controlled, and single-blind study. Aging Male. 2019;1:1–7.
   Google Scholar
• Moitra S. Corticosteroid administration in COPD: summary of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines 2017. Lung Dis Treat. 2017;3:e108.
   Google Scholar
• Canguven O. Effects of heart rate reduction with ivabradine on the International Index of Erectile Function (IIEF-5) in patients with heart failure. Aging Male. 2018;1:1–2.
   Google Scholar
• Ture DA, Demirci H, Sengoren Dikis O. The relationship between health literacy and disease specific costs in subjects with chronic obstructive pulmonary disease (COPD). Aging Male. 2018;1:1–7.
   Google Scholar
• Kulej-Lyko K, Majda J, von Haehling S, et al. Could gonadal and adrenal androgen deficiencies contribute to the depressive symptoms in men with systolic heart failure? Aging Male. 2016;19:221–230.
   PubMed Web of Science ®Google Scholar
• Sin DD. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2005;2:8–11.
   PubMedGoogle Scholar
• Soriano JB, Visick GT, Muellerova H, et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005;128:2099–2107.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165–1185.
   PubMed Web of Science ®Google Scholar
• Jones PW, Brusselle G, Dal Negro RW, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011;105:57–66.
   PubMed Web of Science ®Google Scholar
• Terzano C, Conti V, Di Stefano F, et al. Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung. 2010;188:321–329.
   PubMed Web of Science ®Google Scholar
• Hamid S, Groot W, Pavlova M. Trends in cardiovascular diseases and associated risks in sub-Saharan Africa: a review of the evidence for Ghana, Nigeria, South Africa, Sudan and Tanzania. Aging Male. 2019;1:1–8.
   Google Scholar
• Gupta NK, Agrawal RK, Srivastav AB, et al. Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease. Lung India. 2011;28:105–109.
   PubMedGoogle Scholar
• Das M, Tapadar SR, Mahapatra AB, et al. Assessment of RV function in patients of (COPD). J Clin Diagn Res. 2014;8:11–13.
   PubMedGoogle Scholar
• Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187:347–365.
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–586.
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34:648–654.
   PubMed Web of Science ®Google Scholar
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Updated 2003. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2004;1(1):105–141.
   Google Scholar
• Miller MR. General considerations for lung function testing. Eur Respir J. 2005;26:153–161.
   PubMed Web of Science ®Google Scholar
• Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158:1384–1387.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–1012.
   PubMed Web of Science ®Google Scholar
• Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54:S55–S66.
   PubMed Web of Science ®Google Scholar
• Mullerova H, Agusti A, Erqou S, et al. Cardiovascular comorbidity in COPD: systematic literature review. Chest. 2013;144:1163–1178.
   PubMed Web of Science ®Google Scholar
• Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16:63–70.
   PubMed Web of Science ®Google Scholar
• Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65:956–962.
   PubMed Web of Science ®Google Scholar
• Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis. 2009;4:337–349.
   PubMedGoogle Scholar
• Koc I, Ulusan A. A rare but serious entity: corticosteroid allergy. Ulutas Med J. 2016;2:130–131.
   Google Scholar
• Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med. 2012;186:975–981.
   PubMed Web of Science ®Google Scholar
• Figueira Goncalves JM, Martin Martinez MD, Perez Mendez LI, et al. Health status in patients with COPD according to GOLD 2017 classification: use of the COMCOLD score in routine clinical practice. COPD. 2018;6:1–8.
   Google Scholar
• Cappuccio FP, Miller MA. Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions. Intern Emerg Med. 2016;11:299–305.
   PubMed Web of Science ®Google Scholar
• Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med. 2003;167:735–740.
   PubMed Web of Science ®Google Scholar
• Scharf SM, Iqbal M, Keller C, et al. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med. 2002;166:314–322.
   PubMed Web of Science ®Google Scholar
• Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008;32:1371–1385.
   PubMed Web of Science ®Google Scholar
• Shujaat A, Bajwa AA, Cury JD. Pulmonary hypertension secondary to COPD. Pulm Med. 2012;2012:203952.
   PubMedGoogle Scholar
• Andersen KH, Iversen M, Kjaergaard J, et al. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transplant. 2012;31:373–380.
   PubMed Web of Science ®Google Scholar
• Shanmuganathan A, Advita G, Meenakshi N, et al. Correlation of grade of pulmonary artery pressure with six minutes walk distance and dyspnoea grading in group 3 pulmonary artery hypertension [3 PAH, FEV1, mMRC score, six minute walk distance (6MWD)]. Int J Adv Med. 2018;5:8.
   Google Scholar
• Sims MW, Margolis DJ, Localio AR, et al. Impact of pulmonary artery pressure on exercise function in severe COPD. Chest. 2009;136:412–419.
   PubMed Web of Science ®Google Scholar
• Cuttica MJ, Kalhan R, Shlobin OA, et al. Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respir Med. 2010;104:1877–1882.
   PubMed Web of Science ®Google Scholar
• Ahn YH, Lee KS, Park JH, et al. Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluations. Respiration. 2015;90:199–205.
   PubMed Web of Science ®Google Scholar
• Slenter RH, Sprooten RT, Kotz D, et al. Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease. Respiration. 2013;85:15–26.
   PubMed Web of Science ®Google Scholar
• Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27:2725–2736.
   PubMed Web of Science ®Google Scholar